Show simple item record

dc.contributor.authorTravés, Paqui G
dc.contributor.authorLuque, Alfonso 
dc.contributor.authorHortelano, Sonsoles 
dc.date.accessioned2021-04-29T10:48:13Z
dc.date.available2021-04-29T10:48:13Z
dc.date.issued2012-10-17
dc.identifier.citationOncoimmunology. 2012;1(6): 946-947es_ES
dc.identifier.issn2162-4011es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/12823
dc.description.abstractARF (alternative reading frame) is one of the most important tumor regulator playing critical roles in controlling tumor initiation and progression. Recently, we have demonstrated a novel and unexpected role for ARF as modulator of inflammatory responses.es_ES
dc.language.isoenges_ES
dc.publisherTaylor & Francis es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCanceres_ES
dc.subjectInflammationes_ES
dc.subjectMacrophageses_ES
dc.subjectp19ARFes_ES
dc.subjectTumor suppressores_ES
dc.titleTumor suppressor ARF: The new player of innate immunity.es_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial 4.0 Internacional*
dc.identifier.pubmedID23162766es_ES
dc.format.volume1es_ES
dc.format.number6es_ES
dc.format.page946-947es_ES
dc.identifier.doi10.4161/onci.19948es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.4161/onci.19948es_ES
dc.identifier.journalOncoimmunologyes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial 4.0 Internacional
This item is licensed under a: Atribución-NoComercial 4.0 Internacional